The roles of the prototypical second messengers cyclic AMP (cAMP) and cyclic GMP (cGMP) have been studied for more than 50 years, whereas recognition of the cyclic dinucleotides (CDNs), which are larger signalling molecules, has lagged behind. The first CDN was discovered in 1987, when Moshe Benziman reported "an unusual cyclic nucleotide activator" that was able to stimulate cellulose synthase from Komagataeibacter xylinus (formerly known as Gluconacetobacter xylinus), and identified this compound as bis-(3′-5′)-cyclic diguanylic acid (c-di-GMP) 1 . More than 20 years later, c-di-AMP was discovered as a factor that is involved in DNA repair in Bacillus subtilis 2
, and they were shown to have prominent roles in virulence and the innate immune response, respectively. Despite their chemical similarities, different CDNs seem to have distinct evolutionary origins, and the enzymes that are involved in their synthesis and breakdown are structurally unrelated 2, 5, 6 . The idea that different CDNs evolved in parallel emphasizes the potency and versatility of this macrocyclic ring with two purine moieties, which is the structural component of these biomolecules, as a key carrier of cellular information.
The discovery of CDNs has provided novel entry points for the study of important biological processes and cell behaviour, including how bacteria coordinate their own growth and replication cycle, how they adapt to surfaces by forming multicellular consortia known as biofilms, or how pathogenic bacteria control their virulence and persistence. This was possible by first identifying the enzymes that are involved in the synthesis and degradation of CDNs 7,8 , followed by the characterization of specific effectors and target molecules (see below). The field of CDN research is now rapidly expanding, and aspects of the signalling pathways that are involved are being explored at the atomic, molecular and cellular levels. In the past years, we have learned that CDNs are widespread and immensely versatile signalling molecules that control bacterial cellular processes at several levels, are well integrated with other global regulatory pathways, such as phosphorylation networks 9 and quorum sensing pathways 10 , and crosstalk with other small signalling molecules, including cGMP, cAMP and guanosine tetraphosphate (ppGpp) [11] [12] [13] . In this Review, we discuss the most recent advances in the biology of CDNs with a focus on c-di-GMP signalling. So far, in bacteria, c-di-GMP is not only the most widespread CDN but also the most intensely studied and best-understood member of this family of second messengers. We first summarize the properties of the core components of c-di-GMP metabolism, including the enzymes that are involved in its synthesis and breakdown, as well as effector proteins that convert dynamic changes in c-di-GMP concentration into specific cellular responses. We then highlight recent progress in understanding the most prominent cellular processes that are regulated by c-di-GMP. Although we draw some parallels between c-di-GMP and other CDNs, c-di-AMP signalling in bacteria and the role of cGAMP in the mammalian The requirement for dimerization conveys a simple mechanism to control the activity of DGCs by using an accessory domain that forms homodimers in a signal-dependent manner. In the case of PleD or the DGC WspR in Pseudomonas aeruginosa, this is facilitated by an amino-terminal receiver domain that dimerizes following phosphorylation 5,11-13,21,24 (FIG. 1b) . Recently, an alternative mechanism for the activation of DGCs was proposed for DgcZ from Escherichia coli, which contains a catalytic GGDEF domain that is fused to an N-terminal zinc-binding (CZB) domain. DgcZ is a constitutive dimer and its activity is allosterically regulated by the CZB domain 25 (FIG. 1c) . When zinc is present, the GGDEF domains of DgcZ, although facing each other, are not positioned in a catalytically competent conformation. In the absence of zinc, DgcZ may be activated through the repositioning of the GGDEF domains to enable the formation of phosphodiester bonds between substrate molecules (FIG. 1b) .
The arrangement of the catalytic GGDEF domains was also implicated in the feedback inhibition of c-di-GMP synthesis. Many of these enzymes are subject to non-competitive product inhibition through the binding of c-di-GMP to the allosteric I site on the surface of the GGDEF domain 5, 23 . In PleD and WspR, an intercalated c-di-GMP dimer binds to the I site and a secondary binding site, thereby immobilizing the GGDEF domains in a non-catalytic state 21, 24 (FIG. 1b) . Product inhibition of DGCs may establish precise cellular threshold concentrations of c-di-GMP or contribute to the reduction of stochastic perturbations and increased stability of c-di-GMP signalling networks by maintaining c-di-GMP levels in defined concentration windows 23 . Although a functional connection between the I site and product inhibition has been clearly established, the binding of c-di-GMP to some GGDEF domains may also have other roles, such as in protein-protein interactions 26 (see below). Structurally and mechanistically distinct c-di-GMPspecific PDEs that contain an EAL domain or an HD-GYP domain have been described. EAL-type PDEs hydrolyse
Box 1 | CDNs beyond c-di-GMP
The cyclic dinucleotide (CDN) cyclic di-AMP (c-di-AMP) was discovered as a ligand that was bound to the amino-terminal domain of the DNA damage-sensing protein DisA of Bacillus subtilis 2 . Biochemical studies identified this domain as diadenylyl cyclase (DAC), which is the founding member of a family of enzymes that converts ATP into c-di-AMP. Specific phosphodiesterases (PDEs) that contain DHH-DHHA1 or HD domains hydrolyse c-di-AMP into 5′-phosphoadenylyl-(3′-5′)-adenosine (pApA) or AMP [117] [118] [119] . c-di-AMP is essential in various different bacteria, and dysregulation of c-di-AMP signalling causes abnormal phenotypes 120, 121 . A recent report related the essential nature of c-di-AMP in Listeria monocytogenes to increased levels of guanosine tetraphosphate (ppGpp), which is a global second messenger that has been linked to carbon metabolism and nutrient starvation. Depletion of c-di-AMP in rich media led to an accumulation of ppGpp and altered GTP concentrations, thereby inactivating the pleiotropic transcriptional regulator CodY 122 . In Gram-positive bacteria, c-di-AMP is associated with an increasing list of cellular functions. These functions include cell wall homeostasis 121, [123] [124] [125] [126] , DNA integrity 2, [127] [128] [129] , potassium homeostasis [130] [131] [132] [133] and osmoprotection 134, 135 , gene expression 136, 137 , biofilm formation 138, 139 , sporulation 140 , metabolism 141 , antibiotic resistance 142 , and, similar to c-di-GMP, cell-mediated adaptive immune response (see below).
cGMP-AMP (cGAMP) is of special interest because it is produced by bacteria and metazoans 3, 143 . Bacterial cGAMP exhibits 3′-3′ linkage and is synthesized by the dinucleotide synthase DncV, which was originally identified in Vibrio cholerae
Structural studies have revealed that, in the first nucleotidyl transfer reaction, DncV preferably recognizes ATP and GTP as acceptor and donor nucleotides, respectively 144 . cGAMP is required for host colonization by V. cholerae and for exoelectrogenesis in different members of the Deltaproteobacteria 145, 146 . Mammalian cGAMP (2′-3′ linkage) has a prominent role in a vertebrate innate immunity pathway that is responsible for the surveillance of cytoplasmic DNA 147 . cGAMP is synthesized by cGAMP synthase (cGAS), which is activated by binding to cytoplasmic DNA 148, 149 . In turn, cGAMP binds to and activates the host receptor stimulator of interferon genes (STING), which then recruits TANK-binding kinase 1 (TBK1) to phosphorylate interferon regulatory factor 3 (IRF3), ultimately leading to the production of type I interferon (IFN). Evolutionary studies have recently revealed that the function of the cGAS-STING axis is conserved in sea anemones, which diverged from the human lineage more than 500 million years ago. As cGAS in sea anemones produces a bacteria-like 3′-3′-linked CDN that is recognized by its own STING protein, it was proposed that 2′-3′-linked cGAMP recently evolved in vertebrates and that during evolution the protein components of this innate immunity pathway remained structurally conserved, whereas chemical changes in the second messenger were driving functional innovation 150 . Recent evidence suggests that c-di-GMP and c-di-AMP, which are secreted by bacteria or released through cell lysis, are also sensed by STING, thereby converging with the cGAS-cGAMP cytosolic DNA-surveillance pathway [151] [152] [153] . Interestingly, bacteria seem to have evolved strategies to decrease the production of IFN by avoiding the activation of STING. Group B Streptococcus was recently shown to express an ectonucleotidase, CdnP, which hydrolyses extracellular bacterial c-di-AMP to attenuate the cGAS-STING axis 154 . The c-di-GMP monomer exhibits two-fold symmetry, with two GMP moieties that are fused by a 5′-3′ macrocyclic ring. The synthesis of c-di-GMP is catalysed by diguanylate cyclases (DGCs) through the cooperative action of their two catalytic GGDEF domains (orange). Specific phosphodiesterases (PDEs) that contain EAL or HD-GYP domains (blue) hydrolyse c-di-GMP into 5′-phosphoguanylyl-(3′-5′)-guanosine (pGpG) or GMP, respectively. DGCs are subject to product inhibition through the binding of c-di-GMP to an allosteric I site. Product inhibition of PDEs is accomplished through the competitive binding of pGpG to the active site of the enzyme. Through binding to effector molecules, c-di-GMP regulates diverse cellular processes, including motility, adherence, biofilm formation, virulence, development and cell cycle progression. b | Schematic of DGC activation. The upper panel shows the phosphorylation-dependent activation of PleD from Caulobacter crescentus. The amino-terminal receiver domains and GGDEF domains that are bound to GTP are shown. The phosphorylation-induced dimerization of receiver domains leads to the activation of GGDEF domains. The GTP molecules that are bound by each protomer are positioned in an antiparallel manner to enable the formation of two intermolecular phosphodiester bonds. Binding of c-di-GMP to the I site and to a secondary binding site on the surface of the GGDEF domain immobilizes the enzyme in a catalytically inactive state. The lower panel shows the metal-dependent activation mechanism of DgcZ from Escherichia coli, which contains a catalytic GGDEF domain that is fused to an N-terminal zinc-binding (CZB) domain. DgcZ is a constitutive dimer. In the presence of zinc, the GGDEF domains of DgcZ are not positioned in a catalytically competent conformation. In the absence of zinc, DgcZ may be activated through the repositioning of the GGDEF domains to enable the formation of phosphodiester bonds between the GTP molecules that are bound to each DgcZ protomer. c | Structure of the DgcZ dimer from E. coli (RCSB Protein Data Bank (PDB) entry 4H54) 25 . GGDEF-domains (orange) and zinc-binding CZB domains (grey) are highlighted. Zinc metal ions are depicted as red spheres. The binding of c-di-GMP (magenta) to antipodal inhibitory I sites (IP and IP′ from each protomer, respectively) and the binding of the GTP analogue GTPαS (green) to active sites (A and A′ from each protomer, respectively) are shown. d | Overlay of the EAL domains of the phosphodiesterase PdeL in the tight, substrate-bound conformation (blue; PDB entry 4LJ3) and the relaxed, substrate-free (apo) conformation (grey; PDB entry 4LYK) 28 . The inset shows a zoomed-in view of the active site of PdeL and the conserved loop 6 region. The loop 6 conformations in the relaxed, apo (yellow) and tight c-di-GMP-bound (orange) dimer are indicated. Yellow spheres (Mg 2+ ) and magenta spheres (Ca 2+ ) indicate the positions of catalytic ions in the relaxed and tight protein conformations, respectively. The conserved double-aspartic acid motif (D262, D263) is highlighted. The figure also shows the anchoring glutamate (E235), which determines the structural arrangement of loop 6 through interaction with D263 or the conserved T270, respectively. e | Activation of the membrane-bound BcsA-BcsB cellulose synthase complex by c-di-GMP. The structure of the Rhodobacter sphaeroides BcsA subunit (green), its carboxy-terminal PilZ-domain (magenta) and the BcsB subunit (grey; PDB entry 4P02) are shown 54 . The binding of c-di-GMP to the C-terminal PilZ domain of BcsA releases autoinhibition of its glycosyltransferase activity to activate the complex. A dimer of c-di-GMP bound to the PilZ domain is indicated.
I site
An allosteric binding site for cyclic di-GMP (c-di-GMP) that is responsible for substrate inhibition of diguanylate cyclases.
EAL domain
A catalytic domain of phosphodiesterases that is responsible for the hydrolysis of cyclic di-GMP (c-di-GMP). The EAL domain is named after its conserved signature motif Glu-Ala-Leu and cleaves c-di-GMP into the linear molecule 5′-phosphoguanylyl-(3′-5′)-guanosine (pGpG).
HD-GYP domain
A catalytic domain of phosphodiesterases that is responsible for the cleavage of cyclic di-GMP (c-di-GMP) into two molecules of GMP. The domain belongs to a subclass of HD phosphohydrolases that contain an additional Gly-Tyr-Pro signature motif.
Riboswitches
Regulatory segments of an mRNA that can bind to a small molecule, which results in the altered stability or translation efficiency of the mRNA.
PilZ domain
A small prototypical cyclic di-GMP (c-di-GMP)-binding domain. PilZ domain-containing proteins represent the best-studied class of c-di-GMP effectors.
YajQ protein family
A family of poorly characterized bacterial proteins with motifs that are characteristic of nucleotide-binding or nucleic acid-binding proteins.
ATPases
Enzymes that catalyse the hydrolysis of ATP and harness the energy that is released to drive chemical reactions.
c-di-GMP in the presence of Mg 2+ or Mn 2+ to yield the linear 5′-phosphoguanylyl-(3′-5′)-guanosine (pGpG) dinucleotide 8 . EAL domain-containing proteins are active as dimers 27, 28 , but, in contrast to DGCs, for which the fusion of two GTP molecules requires a dimeric arrangement of the enzyme, this quaternary arrangement does not seem to be required for PDE catalysis. Instead, recent structural studies have implied a regulatory role for EAL domain dimerization. Based on crystal structures, a clam-shell-like opening and closing mechanism of the EAL dimer was proposed to regulate the activity of PDEs 28, 29 . The evolutionarily conserved dimerization interface is formed by two helices, with one of them, α5, directly connecting through the β5-α5 loop (loop 6) to two central Asp residues that coordinate the metal ions in the active site 27, 28, 30 (FIG. 1d) . Structural and biophysical studies revealed that the α5-loop 6 region undergoes substantial rearrangements during the clamlike opening and closing movements of the EAL dimer. These findings indicate that this part of the protein may function as a 'hinge joint' to couple EAL conformation to catalytic activity through the positioning of metal ions in the active site 28, 29 . Consistent with this, accessory domains that are known to control PDE activity communicate with the catalytic core by modulating the conformation of the EAL dimerization interface 29 . The observation that substrate binding induces EAL dimerization and also determines the conformation of the α5-loop 6 region suggested allosteric coupling between EAL domains and the associated regulatory domains, with the α5-loop 6 region acting as a central communication platform [28] [29] [30] . Interestingly, EAL domain-containing proteins that have adopted roles as c-di-GMP effectors seem to use similar c-di-GMP-mediated dimerization and α5-loop 6 remodelling to regulate cellular processes 31 (see below).
A second, unrelated family of c-di-GMP-specific phosphodiesterases contains conserved HD-GYP domains 32 . Recently, the first crystal structure of an active HD-GYP-containing PDE was solved and indicated that a novel trinuclear iron-binding site is involved in catalysis 33 . Whereas EAL-based enzymes generally convert c-di-GMP into the linear product pGpG, HD-GYP hydrolyses c-di-GMP in a one-step reaction to yield two molecules of GMP 33 . Thus, for bacteria that lack HD-GYP domain-containing proteins it remained unclear how pGpG is further catabolized into GMP. This puzzle was solved recently by studies that showed that the oligoribonuclease Orn, which is a ribonuclease that hydrolyses RNAs that are 2-5 nucleo tides in length, is the primary enzyme that is capable of degrading pGpG 34, 35 . Despite detailed knowledge on the structure and function of DGCs and PDEs, it has remained challenging to assign physiological roles to individual enzymes under laboratory conditions 36 . Genetic studies often fail to reveal clear phenotypes. Thus far, only a few specific input signals have been identified for these enzymes, including oxygen 37 , light 27 , nitric oxide 38 , metals 25 , nutrients 39, 40 or surface contact 41 , which may be owing to the limited physiological conditions that are assayed in the laboratory. Evidence for this was provided by a recent study of PDEs in E. coli. Despite a total of 13 PDEs being encoded in the genome of this organism, only PdeH is able to decrease c-di-GMP levels and license motility in growing E. coli cells 42, 43 (see below). The observations that most PDEs are readily expressed and that a large proportion of these enzymes can be genetically activated to substitute for PdeH in motility control implied that most of these enzymes simply lack the appropriate stimuli under laboratory conditions 44 . DGCs and PDEs also engage in downstream signalling cascades through direct interactions with their effector molecules, thereby spatially controlling cellular processes 26, 37, 45 . In such supramolecular complexes, these proteins not only regulate the synthesis and degradation of c-di-GMP but can also act as 'c-di-GMP sensors' to control the activity of interacting proteins 45 .
c-di-GMP effectors
Although the coordinated control of makers and breakers explains how c-di-GMP levels are controlled in time and space, c-di-GMP pathways ultimately rely on the respective effectors that bind to c-di-GMP and on their downstream targets, which are the cellular components that are regulated by specific c-di-GMP effectors. Given the global influence of c-di-GMP on bacterial cell physi ology and the sheer abundance of DGCs and PDEs in some bacteria, it can be assumed that numerous such effectors and cellular targets exist. Several families of effector proteins and RNAs have been identified and are structurally and functionally well characterized 46 . These include mRNA riboswitches 47 , transcriptional regulators [48] [49] [50] , proteins that contain PilZ domains 43, 51, 52 , and proteins that contain degenerate GGDEF and EAL domains 53 . The field has recently come full circle; the discovery of c-di-GMP goes back to the observation that c-di-GMP activates the membrane-bound BcsA-BcsB cellulose synthase complex in K. xylinus, thereby increasing the production of this exopolysaccharide matrix component The discovery that c-di-GMP binds to a range of transcription factors, including members of the response regulator or cAMP-responsive protein (Crp) families, in a way that was not predictable from their protein sequence, argued for a more versatile nature of ligand-effector interactions 48, 56, 57 . This is supported by the identification and characterization of a range of novel c-di-GMP effectors, an endeavour that was greatly aided by the introduction of innovative high-throughput methods and biochemical techniques
. One of the most exciting recent discoveries was the finding that ATPases bind to c-di-GMP. The first example is FleQ, which is a bacterial Mannose-sensitive haemagglutinin pili (MSHA pili). Type IV pili with haemagglutinating activity that are inhibited by mannosides.
Sensor histidine kinases
Enzymes that autophosphorylate a conserved histidine residue and transfer this moiety to the receiver domain of a response regulator.
enhancer-binding protein (bEBP) from P. aeruginosa. Whereas other members of this family of transcription factors are normally activated by phosphorylation, the activity of FleQ is controlled by c-di-GMP 49 . Structural studies have revealed that c-di-GMP interacts with the AAA+ ATPase domain of FleQ at a site that is distinct from the ATP-binding pocket. The binding of c-di-GMP obstructs the ATPase activity of FleQ, thereby altering its quaternary structure and its transcriptional activity 57 . In other bacteria, specific homologues of FleQ have also been identified as c-di-GMP effectors 58, 59 . Similarly, c-di-GMP specifically binds to MshE, which is an AAA+ ATPase that is involved in the assembly of mannose-sensitive haemagglutinin pili (MSHA pili) in Vibrio cholerae [60] [61] [62] . The observation that HxrA, which is an MshE homologue and type 2 secretion (T2S) ATPase from P. aeruginosa, also specifically binds to c-di-GMP opened up the exciting possibility that this protein secretion pathway, which uses a pilus-like extrusion mechanism, might also be controlled directly by c-di-GMP 60 . The idea that c-di-GMP globally controls bacterial protein secretion is reinforced by some recent observations that indicate that this second messenger also controls type VI secretion systems (T6SSs) 63 , as well as T3SSs 64 . Although the exact role of c-di-GMP in T6SSs remains unclear, its effect on T3SSs seems to be direct and again mediated through a central ATPase, as it was shown that the flagellar export ATPase FliI from a range of distantly related bacteria specifically binds to c-di-GMP 64 . The binding of c-di-GMP to FliI, and to its homologues HrcN and ClpB2 from the T3SS and T6SS, respectively, inhibits ATPase activity, which suggests that it directly interferes with flagellar export and T3S-mediated protein secretion. The authors of this study proposed that the mechanism of c-di-GMP binding might be widely conserved among the rotary export ATPases, which makes c-di-GMP central to the function of many of these secretion proteins 64 . It will be interesting to compare the c-di-GMP binding mode of the individual members of this family once structural information is available.
Finally, sensor histidine kinases, which are the central components of phosphorylation pathways in bacteria, have also been identified as targets of c-di-GMP. The histidine kinase cell cycle kinase A (CckA) from C. crescentus was shown to bind to c-di-GMP through its catalytic and ATPase domains, which leads to a shift in the kinase-phosphatase activity of this bi functional enzyme 9 (see below). The discovery that several ATPases act as regulatory hubs for c-di-GMP may reflect the global role of c-di-GMP in monitoring bacterial cell physiology. ATPases often function as central regulatory switches that govern key cellular processes and c-di-GMP seems to control the activity of some of these essential enzymes.
Physiological roles of c-di-GMP Development and morphogenesis. Several bacteria use c-di-GMP to control morphogenesis and developmental transitions. This includes C. crescentus, which is an aquatic organism that has an inherently asymmetric life cycle 65 (FIG. 2) . C. crescentus produces two specialized progeny cells during each division cycle -a motile swarmer cell and a sessile stalked cell. Dividing C. crescentus cells are highly polarized, with a stalk and adhesive holdfast exposed at one cell pole and a flagellum, pili and chemotaxis apparatus assembled at the opposite pole. The surface-attached stalked cell progeny reinitiates chromosome replication (S phase) and cell division (G2 phase) immediately, whereas the new swarmer cell is motile but blocks replication for an extended period called G1 phase. Replication and division resume when the swarmer cell differentiates into a stalked cell, a process during which it ejects its flagellum, retracts its pili and replaces them with a holdfast and a stalk 65 (FIG. 2) .
Box 2 | Toolkit for the analysis of CDN and CDN-binding proteins
Several tools and biomarkers were established for the in vitro and in vivo analysis of cyclic di-GMP (c-di-GMP). This includes sensitive high-performance liquid chromatography-coupled tandem mass spectrometry (HPLC-MS/MS) to accurately determine the concentration of second messengers in cell extracts 155, 156 , fluorescence-based reporters that are fused to c-di-GMP-dependent promoters or riboswitches [157] [158] [159] [160] , and a c-di-GMP-specific fluorescence resonance energy transfer (FRET) probe that enables direct measurements of c-di-GMP concentrations in individual live cells 68, 77 . In the past five years, novel approaches were developed to identify and characterize cyclic dinucleotide (CDN) effector proteins on a global scale. This included affinity pull-down assays followed by mass spectrometry analysis. Trivalent chemical scaffolds with a CDN-binding, a biotin-sorting and a crosslinking moiety were used as capture compounds in combination with streptavidin-coated magnetic beads 161, 162 . A similar approach used c-di-GMP-coated sepharose beads for affinity pull-down assays 163 . The advantage of these methods is that potential binding proteins can directly be isolated from cell extracts without the need for time-consuming fractionation or biochemical purification. Moreover, once specific binding proteins have been identified, such pull-down methods can also be used for diagnostic purposes in combination with specific antibodies 92 . Both methods were successfully applied for different bacteria, including Pseudomonas aeruginosa, Salmonella enterica subsp. enterica serovar Typhimurium, Caulobacter crescentus, Listeria monocytogenes, Streptomyces venezuelae or Bdellovibrio bacteriovorus 50, 141, 161, 164 . A more indirect approach involves the screening of the complete genome-scale ORF library (ORFeome) and the subsequent testing of cell lysates with a high-throughput binding assay 60, 165 . Differential radial capillary action of ligand assay (DRaCALA) was developed to directly mix proteins with labelled nucleotides (such as radiolabelled nucleotides) on a nitrocellulose membrane. After washing the membrane, free ligands will diffuse away, whereas ligands that are specifically bound to proteins will be immobilized at the contact site 165 . The application of these techniques, as well as more conventional approaches, such as isothermal titration calorimetry (ITC) or microscale thermophoresis (MST), has led to the identification of numerous novel effector proteins 60, 64, 130, 163 .
Birth scar protein
A protein that is positioned at the site of cytokinesis and acts as a marker for the newly formed poles of daughter cells after cell division.
Recent studies identified c-di-GMP as a major driver of pole morphogenesis and cell cycle control in C. crescentus 9, 66, 67 . Mutants that were unable to synthesize c-di-GMP lost all polar appendages and showed marked cell morphology aberrations 67 . Levels of c-di-GMP oscillate during the cell cycle of C. crescentus, with trough values in the motile swarmer cell, a peak during the swarmer-to-stalked cell transition and intermediate concentrations during division 67, 68 (FIG. 2) . The increase in the concentration of c-di-GMP during the swarmer-to-stalked cell transition is mainly promoted by PleD, which is a DGC that is activated by phosphorylation when cells enter S phase 67, 69 . The activity of PleD is confined to the stalked cell by two antagonistic histidine kinases, PleC and DivJ, which are positioned at opposite poles of dividing cells and differentially segregate into swarmer cell and stalked cell progenies (FIG. 2) . Whereas PleC functions as a phosphatase that keeps the levels of phosphorylated PleD low in swarmer cells, DivJ functions as a kinase to drive the phosphorylation of PleD in stalked cells 69 . In addition, counteracting PDEs are thought to keep c-di-GMP levels low in the motile swarmer cell. One of these PDEs, PdeA, localizes to the flagellated pole before division and later partitions into the new swarmer cell, in which it promotes motility by keeping c-di-GMP levels low. PdeA is removed by specific proteolysis during the swarmer-to-stalked cell transition, which coincides with the activation of PleD, thereby contributing to the sharp increase in c-di-GMP at this stage of the cell cycle 66 . But how does the oscillation of c-di-GMP instigate the exact timing of cell cycle events in C. crescentus? One example is illustrated by the TipF-TipN pathway, which regulates flagellar polarity. Following the binding of c-di-GMP, TipF localizes to the pole opposite to the stalk, where it binds to its polar receptor, the birth scar protein TipN 70 (FIG. 2a) . TipF then recruits flagellar proteins to this subcellular site to initiate flagellar assembly in the pre-divisional cell. TipF is stable when bound to c-di-GMP but is rapidly degraded when c-di-GMP levels decrease in the swarmer cell (FIG. 2b) . The removal of TipF was proposed to reset the flagellar polarization state and avoid incorrect positioning of the flagellar motor at the incipient stalked cell pole 70 . Recent studies also linked oscillations of c-di-GMP to the G1-S phase transition and control of chromosome replication 9 . The transcription factor cell cycle transcriptional regulator A (CtrA) is phosphorylated and active in swarmer cells (G1 phase) in which it binds to the C. crescentus origin of replication (Cori) to block replication initiation 65 (FIG. 2b) . During differentiation into stalked cells, CtrA is inactivated and replication is initiated. The activity of CtrA is controlled by the bifunctional cell cycle histidine kinase CckA, which phosphorylates and thus activates CtrA through the phosphotransferase protein ChpT. CckA exhibits kinase activity in the swarmer cell but adopts marked phosphatase activity during the G1-S transition, thereby reversing the phosphate flux through the CckA-ChpTCtrA cascade and inactivating CtrA. Concurrent with its dephosphorylation, CtrA is degraded by the ClpXP protease 65 (FIG. 2c) . Both the dephosphorylation and degradation of CtrA are controlled by the increase in c-di-GMP during the G1-S phase transition. The degradation of CtrA is mediated by the ClpXP protease adaptor PopA, which binds to c-di-GMP and delivers CtrA to the protease 53, 71, 72 , whereas the dephosphorylation of CtrA results from c-di-GMP directly interfering with the 
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Vegetative hyphae
Filamentous, fungal-like cellular structures in a medium or on a colony surface.
CckA kinase-phosphatase switch (FIG. 2d) . Biochemical and structural studies have shown that c-di-GMP binds to the catalytic and ATP-binding domain of CckA, thereby inhibiting its default kinase activity and stimulating its phosphatase activity 9, 73 . By controlling a key cell cycle kinase to drive the G1-S phase transition in C. crescentus, c-di-GMP has adopted a role similar to cyclins in eukaryotes, which drive the cell cycle by regulating the activity of cyclin-dependent kinases 74 . Moreover, c-di-GMP spatially controls the activity of CckA during division to promote the asymmetric replication of future daughter cells. In predivisional cells, CckA localizes to opposite cell poles, adopting kinase and phosphatase activity at the flagellated and stalked pole, respectively (FIG. 2) . This leads to a gradient of phosphorylated CtrA in the cell and to the asymmetric initiation of replication, with Cori at the stalked cell pole being activated before cell division is completed, whereas the Cori at the flagellated pole remains inactive 75, 76 . The asymmetric distribution of c-di-GMP was proposed to control the differential activity of CckA at opposite poles. Although the bulk of dividing cells experience high levels of c-di-GMP, a microenvironment that has low levels of c-di-GMP was proposed to promote the kinase activity of CckA at the flagellated pole 9 (FIG. 2) . The authors of this study proposed that this mechanism could shield CckA molecules that are sequestered to the flagellated pole from the cellular pool of c-di-GMP. How such a microenvironment with low c-di-GMP levels is organized and which PDEs are involved in this spatial control remain to be shown.
The asymmetric distribution of c-di-GMP during cell division was also observed in other bacteria, which argues that this might represent a general principle to control cell behaviour and/or reproduction 68 . For example, during the cell cycle of P. aeruginosa, c-di-GMP levels decrease a short period after cell division in the daughter cell that inherits the polar flagellum. This pattern is caused by the asymmetric distribution of Pch, which is a PDE that localizes to the chemotaxis machinery at the flagellated cell pole during division 77 . Similar to the G1 phase of the cell cycle of C. crescentus, a decrease in c-di-GMP at this stage of the cell cycle of P. aeruginosa may promote diversity in the swimming behaviour, which, in turn, could help P. aeruginosa to adapt to new environments.
In addition to contributing to cell polarity and the determination of cell fate in unicellular bacteria, c-di-GMP also controls complex multicellular behaviour in bacteria. For example, streptomycetes undergo an elaborate life cycle with two distinct filamentous cell forms. Germinating spores develop into vegetative hyphae, which grow into a substrate to scavenge nutrients. Following nutrient depletion, aerial hyphae are formed, which eventually differentiate into long chains of spores 78 . Recently, c-di-GMP was found to have a key role in the transition from vegetative mycelial growth to the formation of a reproductive aerial mycelium 50 . The deletion of genes that encode proteins that are involved in the metabolism of c-di-GMP had a notable effect on colony morphology and development 78 . Moreover, increasing internal levels of c-di-GMP blocked development, whereas decreasing levels of c-di-GMP caused premature spore production by bypassing the formation of aerial hyphae 50 . Premature sporulation is also observed in mutants that lack BldD, the master regulator of Streptomyces development that represses a global regulon of approximately 170 sporulation genes 78 . Recently, a direct connection between these two key components of developmental control was identified when BldD was shown to be a c-di-GMP effector protein that represses its target genes in a manner that is dependent on c-di-GMP binding 50 . Thus, a decrease in cytoplasmic levels of c-di-GMP may cause the disassembly of the BldD dimer and its inactivation, and thus the induction of sporulation genes. Other studies in Myxococcus xanthus 58, 79 , Bdellovibrio bacteriovorus 80 and cyanobacteria 81 further highlight the broad effect of c-di-GMP on development and morphogenesis in bacteria. Motile-sessile transition and biofilm formation. Controlling the motile-sessile transition of bacteria is a universal feature of c-di-GMP. Generally, low levels of c-di-GMP are associated with the motility of individual cells, whereas increased concentrations of c-di-GMP promote surface attachment and the formation of biofilms. However, rather than being a simple on-off switch, complex regulatory steps seem to be involved in a multistage process that leads to surface colonization 82 . In line with the idea that motility is one of the primary processes that is targeted by c-di-GMP, the assembly and activity of the bacterial flagellar motor is highly regulated by this second messenger. This includes the regulation of flagellar gene expression 48, 49 , motor assembly 64, 70 and motor function 43, 83 . Although controlling flagellar gene expression is likely to be part of a longterm adaptation strategy, tuning motor activity might be important for bacteria to rapidly change their behaviour during the colonization of a surface. For example, in E. coli and Salmonella enterica subsp. enterica serovar Typhimurium, increased levels of c-di-GMP result in the obstruction of motor function by the c-di-GMP effector protein YcgR, which, in its c-di-GMP-bound form, interacts with the flagellar rotor-stator interface 43, 84, 85 (FIG. 3a) .
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To block the activity of YcgR and promote swimming, these bacteria co-express the PDE PdeH and flagellar genes. A similar mechanism was proposed to tune motility in B. subtilis, in which PdeH controls motility by preventing flagellar obstruction by the YcgR homologue DgrA 86 . YcgR homologues also control flagellar function in pseudomonads 87, 88 . Intriguingly, in P. aeruginosa, the YcgR homologue FlgZ controls swarming motility by specifically interacting with the MotC-MotD flagellar stator, which is required for surface-associated motility 87 . YcgR in E. coli exhibits high binding affinity for c-di-GMP, which suggests that small spikes in the level of Nature Reviews | Microbiology 
Extracellular matrix
A self-produced and secreted polymeric matrix that consists of sugars, proteins and DNA, in which bacteria are embedded within a surface-grown biofilm.
σS
A sigma factor in gammaproteobacteria that is a central regulator of the general stress response and of gene expression in stationary phase.
c-di-GMP are sufficient to adjust the flagellar motor and to initiate surface attachment. Consecutive steps of surface colonization may involve an incremental increase in the level of c-di-GMP and the sequential activation of distinct cellular processes, such as surface motility or the production of adhesins and components of the biofilm matrix. This could be accomplished through the successive involvement of DGCs that have distinct levels of feedback inhibition 23 and through the activation of c-di-GMP receptors that have gradually decreased affinities 89 . For example, in P. aeruginosa, different DGCs, PDEs and effector proteins are required at discrete stages of biofilm formation 82 .
On contact with a surface, bacteria rapidly change their behaviour, expose adhesins, activate surface organelles and produce an extracellular matrix to protect developing microcolonies. This adaptation is coordinated by c-di-GMP at the transcriptional (see, for example, REF. , C. crescentus 67 or Clostridium difficile 95 (see below). Similarly, in E. coli, the production of the two principal biofilm matrix components -curli fibres and cellulose -is regulated by c-di-GMP 96 . During biofilm formation, c-di-GMP levels increase as a result of σS (also known as RpoS)-induced expression of DgcE (formerly known as YegE) 42 and other DGCs, and the consecutive downregulation of the PDE PdeH (formerly known as YhjH) 42 , which acts as a gatekeeper for motility and is part of the large flagellar regulon 43, 97 . Increased global levels of c-di-GMP induce a local control module that consists of DgcM and PdeR, which form a DGC-PDE pair that directly interacts with and stimulates the transcription factor MlrA (FIG. 3b) ; this activates the expression of the central curli regulator CsgD. Interestingly, PdeR and DgcM do not primarily exhibit a catalytic role but rather sense the global increase in c-di-GMP and function as co-activators for MlrA 45 . CsgD then induces the transcription of curli genes and dgcC, which encodes the primary DGC that stimulates the synthesis of c-di-GMP, which, in turn, allosterically activates the production of cellulose by binding to the BcsA-BcsB complex 54 (FIGS 1e,3b). This is a key example of how different levels of the c-di-GMP signalling network are interconnected to gradually activate and coordinate a cellular response, which, in this case, tunes the expression of matrix components. An alternative exopolysaccharide, poly-β-1,6-N-acetylglucosamine (PGA), can promote surface adherence and biofilm formation in E. coli. The biogenesis and secretion of PGA require the Pga complex (comprising PgaA, PgaB, PgaC and PgaD) and its allosteric activation by c-di-GMP. Both the pgaABCD operon and the genes that encode the two DGCs, DgcT and DgcZ, are controlled by the carbon storage regulator (Csr) system, a global regulatory system that mediates virulence and biofilm formation in E. coli 98 . Recent findings indicate that c-di-GMP activates the Pga complex by binding directly to both PgaC and PgaD, which are the two inner membrane components of the Pga complex, to stimulate their glycosyltransferase activity 92 (FIG. 3c) .
Although the processes that drive biofilm formation are relatively well understood, the mechanisms that underlie biofilm dispersal have remained understudied. Given the prominent role of c-di-GMP in biofilm formation, careful control of the levels of this second messenger must also be linked to active biofilm dispersal 99 . A potential escape mechanism was identified in Pseudomonas fluorescens, in which the LapA surface protein mediates surface adhesion and the stabilization of biofilms 100 . At high c-di-GMP levels, c-di-GMP binds to LapD to help sequester the LapG protease in the periplasm. When c-di-GMP levels decrease following the induction of the PDE RapA, LapD is inactivated, thereby releasing the protease to cleave the LapA adhesin and weaken the biofilm (FIG. 3d) .
As biofilms contribute to acute and chronic infections, it is not surprising that the c-di-GMP network is under selective pressure in human patients. Slowgrowing autoaggregative P. aeruginosa isolates from the respiratory tracts of patients with cystic fibrosis were shown to have mutations that lead to marked activation of some of the major DGCs 101, 102 . The observation that such variants effectively persisted in animal models In its c-di-GMP-bound form, the c-di-GMP effector YcgR interacts with and curbs the flagellar motor, which leads to the obstruction of motor function. PdeH inactivates YcgR by keeping c-di-GMP levels low and thereby enabling motor function. b | c-di-GMP-dependent production of the biofilm matrix components amyloid curli fibres and cellulose in E. coli. The global DgcE and PdeH module controls the overall levels of c-di-GMP, and increased levels of the second messenger are sensed by the local DgcM and PdeR module to activate the transcription factor MlrA. This transcription factor induces the expression of the global transcription factor CsgD, which then activates the expression of curli components and DgcC. In turn, DgcC stimulates the synthesis of c-di-GMP, which allosterically activates the production of cellulose by binding to the BcsA-BcsB complex. c | c-di-GMP-mediated synthesis of the alternative exopolysaccharide poly-β-1,6-N-acetyl-glucosamine (PGA) in E. coli. The biogenesis and secretion of PGA require the Pga complex, which comprises the two transmembrane proteins PgaA and PgaB, and the two inner membrane components PgaC and PgaD. The carbon storage regulator (Csr) global regulatory system represses the pga genes, which encode components of the PGA synthesis machinery (PgaA, PgaB, PgaC (represented by single letter 'C' in this panel) and PgaD (represented by single letter 'D' in this panel)), and dgcT and dgcZ, which encode two diguanylate cyclases (DGCs) that are responsible for the allosteric activation of PgaC and PgaD. The histidine kinase BarA is stimulated by short-chain fatty acids and activates the expression of two small RNAs, CsrB and CsrC, through the phosphorylation of the response regulator UvrY. In turn, CsrB and CsrC antagonize the translation inhibitor CsrA and thus enable the expression of pga, dgcT and dgcZ. Intracellular levels of c-di-GMP increase through the action of DgcT and DgcZ. The binding of c-di-GMP to PgaC and PgaD allosterically activates the Pga complex. d | Biofilm dispersal mechanism in Pseudomonas fluorescens Pf0-1. The LapA surface protein mediates surface adhesion and contributes to the stabilization of biofilms in P. fluorescens. Under conditions of phosphate starvation, LapA is degraded by the periplasmic protease LapG, which results in biofilm dispersal. If enough phosphate is available, LapG is sequestered by its partner LapD in its c-di-GMP-bound conformation. When phosphate becomes limited, the phosphodiesterase (PDE) RapA is expressed through the Pst-PhoR-PhoB phosphate control system, which leads to a decrease in the levels of c-di-GMP, a conformational change in apo-LapD and the release of the LapG protease, which cleaves the LapA adhesin. pGpG, 5′-phosphoguanylyl-(3′-5′)-guanosine. 
Shiga-toxin
A family of related toxins that are expressed and secreted by various enteric pathogens, and inhibit protein synthesis in eukaryotic target cells.
and in the presence of subinhibitory concentration of antibiotics, despite decreased growth rates in vitro, indicated that they may have an important role in persistence during antimicrobial chemotherapy 101 .
Role of c-di-GMP in bacterial virulence. The virulence of animal and plant pathogens has been shown to be modulated by c-di-GMP 14 . Processes that are controlled by c-di-GMP include host cell adherence, the secretion of virulence factors, cytotoxicity, invasion, resistance to oxidative stress and the modulation of the immune response of the host. Importantly, recent findings have linked c-di-GMP to the most prominent secretion systems for virulence factors, including T2SSs, T3SSs and T6SSs 60, 63, 64 . This opens up the possibility that c-di-GMP interferes with these processes on a more global scale. Studies in C. difficile have highlighted the importance of c-di-GMP in virulence. In contrast to most Gram-positive bacteria, C. difficile encodes numerous enzymes that are involved in the turnover of c-di-GMP 103 . During the course of infection, C. difficile undergoes a c-di-GMP-mediated switch from a motile to a surfaceadherent state, whereby cells adhere to the intestinal mucosa through T4P and other adhesins 104 . This transition is mediated by a total of 16 c-di-GMP-responsive riboswitches, 12 of which are off switches (type I) and four are on switches (type II) 105 . Through these regulatory elements, c-di-GMP controls the expression of flagella, pili, adhesion factors and other virulence factors, including the toxins TcdA (also known as ToxA) and TcdB, which are the main virulence factors of C. difficile 95, [105] [106] [107] [108] (FIG. 4) . For example, a collagen-binding protein (CBP) and its specific protease are inversely controlled by type I and type II riboswitches, respectively 105 . Expression of the protease at low c-di-GMP concentrations effectively prevents host cell adherence, whereas expression of the CBP at high c-di-GMP concentrations promotes attachment to host tissue. Thus, c-di-GMP-mediated riboswitches control C. difficile host colonization by coordinating motility, toxin production, surface adhesion and biofilm formation.
The prominent role of c-di-GMP in virulence is exemplified by the outbreak of E. coli O104:H4 in Germany in 2011, which caused an unusually high incidence of haemolytic uraemic syndrome (HUS) 109 . The genome of the causative strain showed characteristics of both enterohaemorrhagic E. coli (EHEC) and enteroaggregative E. coli (EAEC), and revealed the presence of a highly expressed DGC (encoded by dgcX), which is prevalent in EAEC O104:H4 strains 110 . This indicated that the outbreak strain and EAEC in general produce high levels of c-di-GMP and are likely to form biofilms in the host. The observation that dgcX is inserted at the attB locus, the integration site for phage λ, and is flanked by prophage elements, suggested that the gene was acquired by horizontal gene transfer. The analysis of E. coli O104:H4 also emphasized the key importance of adaptation and regulatory flexibility of the c-di-GMP network. Although marked adherence, together with the expression of Shiga toxin, is a key virulence factor of E. coli O104:H4, this strain produces curli but is cellulose negative. The authors of this study speculated that the marked pro-inflammatory effect of curli, together with the absence of cellulose (which normally counteracts this effect), may facilitate entry into the bloodstream and kidneys, in which this pathogen can cause life-threatening HUS 110 . Given their widespread abundance in bacteria and their importance in bacterial virulence, it is not surprising that bacterial CDNs are sensed by the immune system of the host. Recent evidence suggests a prominent role for c-di-GMP and c-di-AMP as pathogenassociated molecular patterns (PAMPs), which are specifically recognized by the innate immune system of the host
.
Conclusion and outlook
In this Review, we have summarized some of the recent findings that describe the mechanistic and functional aspects of c-di-GMP signalling in bacteria. Although c-di-AMP was discovered more recently, the field is rapidly advancing and exposing a physiological complexity that is comparable to the c-di-GMP network
. It is possible that additional CDNs still await discovery, providing even greater signalling diversity by varying either the Nature Reviews | Microbiology nucleotide composition or linkage chemistry. However, why are CDNs so prevalent in the control of important biological processes in bacteria? One major advantage of second messenger-based networks over other information-transfer systems that are based on protein-protein interactions might be the ease with which they are able to evolve. For example, the recruitment of additional cellular processes into an existing c-di-GMP network seems relatively straightforward, considering that c-di-GMP often binds to the surface of pre-existing protein domains with only a few amino acids that contribute to ligand affinity and specificity (FIG. 5a) . Simple recruitment of additional effectors, together with the rapid expansion of makers and breakers by gene duplication, might thus have predisposed CDN-based regulatory networks for the coordination of global metabolic and behavioural transitions in bacteria.
CDN-based second messengers also provide various advantages in signal transduction. On the one hand, their rapid cellular diffusion stages an instantaneous and global internal response. On the other hand, CDNs may act in a highly specific manner either through temporal or spatial control 111, 112 . For example, the combination of DGCs or PDEs that have distinct inhibition constants and substrate affinities, respectively, together with effector proteins or RNAs of matching c-di-GMP affinities would permit cells to regulate different processes in a highly specific manner (FIG. 5b) . Alternatively, the spatial organization of DGCs and/or PDEs that interact directly with their respective targets, together with effective mechanisms that isolate individual signalling modules from each other, would permit parallel CDN signalling modules with highly specific readouts (FIG. 5c) . CDNs, such as c-di-GMP, control the expression, Nature Reviews | Microbiology Minor modifications to the surface of a specific protein can mediate the specific binding of cyclic di-GMP (c-di-GMP; rendering it an effector protein (E)), which, in turn, can modulate the activity and stability of the protein (E2) or its interaction with a partner (E-E′). b, c | The network architecture that is involved in pathway-specific signalling. c-di-GMP-dependent processes can be specifically regulated by temporal (part b) or spatial (part c) separation. Temporal regulation can depend on effector proteins with different ligand-binding affinities (K d ) and on diguanylate cyclases (DGCs) and/or phosphodiesterase (PDEs) with specific inhibition (K i ) and activation constants (K m ), respectively. This mode of regulation establishes precise cellular thresholds of c-di-GMP levels, thereby activating specific downstream effectors and pathways. Spatially separated signalling relies on some form of compartmentalization. For example, a specific DGC-PDE module (DGC1-PDE1 or DGC2-PDE2) interacts with its specific effector (E1 or E2, respectively). To avoid unwanted crosstalk between individual DGC-PDE modules and other effectors and cellular pathways, spatially confined modules need to be effectively separated. This can occur through the action of the module-specific PDE (PDE1 or PDE2) or by a general cellular PDE that prevents the leakage of c-di-GMP into other compartments. d | c-di-GMP can control the same biological process at different levels. For example, c-di-GMP can control gene expression (transcription and translation) or the activity of one of the resulting proteins. Expression and allosteric control can be mediated by the same module, comprising a DGC and PDE, or can be modulated independently by different DGC and PDE modules. c-di-GMP molecules are indicated as blue circles or as a spatial gradient in part c.
Which cellular activities do specific CDN networks control and how extensively do these compounds interfere with basic cellular processes in bacteria? What are the important environmental input signals that control these regulatory systems? What is the exact architecture of CDN networks and how do they contribute to the highly dynamic behaviour of bacterial cells? Finally, how are CDN-based networks integrated with other signalling networks, such as quorum sensing pathways, phosphorylation cascades or ppGpp-dependent pathways? It is safe to predict that this field of research will continue to provide exciting novel insights into bacterial signalling, growth and behaviour. Future steps should include the development of tools to quantitatively describe CDN network dynamics. This will provide the basis for the mathematical description of these systems and eventually afford the predictive power to experimentally test and refine important network parameters. Moreover, the field has now advanced sufficiently to re-evaluate the therapeutic potential of CDNs. For example, agonists of the host receptor stimulator of interferon genes (STING) are currently being explored as candidate stimulants for anticancer immune activity 114 . Given that STING has been shown to bind to c-di-GMP and c-di-AMP
, similar approaches could be assessed as strategies for the treatment of bacterial infections 115, 116 .
